Mission Statement, Vision, & Core Values of Stevanato Group S.p.A. (STVN)

Ever wonder what drives a leading global provider of drug containment, drug delivery, and diagnostic solutions like Stevanato Group? Is it just about the €1.104 billion in revenue they reported for fiscal year 2024, or is there something more profound at its core?

Dive in to explore the mission, vision, and core values that steer Stevanato Group (STVN), a company deeply rooted in ensuring the integrity of medicines and improving patient lives. How do these guiding principles translate into their daily operations and strategic decisions, and what impact do they have on the broader pharmaceutical and biotechnology industries?

Discover how Stevanato Group's commitment to innovation, ethical practices, and customer success shapes its approach to delivering advanced solutions in the healthcare sector. What are the values that underpin their pioneering work, and how do they strive to exceed customer expectations while upholding the highest standards of product integrity?

Stevanato Group S.p.A. (STVN) An Overview of

Stevanato Group S.p.A. is a global company focused on providing drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. Founded in 1949, the company has grown from a glass manufacturer to a comprehensive provider of integrated solutions, including specialized glass tubing, molded glass vials, syringes, and cartridges, as well as engineering and automation equipment for pharmaceutical manufacturing. As of April 2025, Stevanato Group continues to expand its global footprint, serving a diverse clientele with a strong emphasis on innovation and quality.

In 2024, Stevanato Group reported record-breaking revenue, driven significantly by the demand for its high-value solutions like pre-fillable syringes and cartridges used in novel drug delivery systems. The company saw substantial growth in key markets, including North America and Europe, fueled by both organic expansion and strategic acquisitions. Specifically, sales of its primary product lines, such as molded glass containers and automation equipment, contributed significantly to the overall revenue increase. This financial success reflects Stevanato Group's ability to capitalize on the increasing complexity and stringent requirements of the pharmaceutical industry, where precision and reliability are paramount.

Stevanato Group stands as one of the leading companies in the biopharmaceutical and diagnostic industries, offering a broad spectrum of solutions designed to meet the evolving needs of healthcare providers and patients. Its success is rooted in a commitment to quality, innovation, and customer service, making it a preferred partner for pharmaceutical companies worldwide. To delve deeper into the financial well-being of Stevanato Group, read more here: Breaking Down Stevanato Group S.p.A. (STVN) Financial Health: Key Insights for Investors.

Stevanato Group S.p.A. (STVN) Mission Statement

Stevanato Group S.p.A. (STVN) is a global company focused on providing drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. Founded in 1953 and headquartered in Piombino Dese, Italy, the company has evolved into a key player in the pharmaceutical packaging and engineering sectors.

The company's mission is to create systems, processes, and services that guarantee the integrity of parenteral medicines. Through continuous innovation and pioneering of new trends, Stevanato Group is committed to making a vital contribution to the pharmaceutical industry and ultimately offering superior solutions to its customers, for patient safety. As part of this mission, the company is dedicated to offering 'synchronized solutions' that work together to significantly enhance the product integrity that can be guaranteed to patients, thereby exceeding customer expectations year after year.

Stevanato Group's mission statement embodies several core components:

• Innovation: The company invests in research and development to pioneer new trends and technologies. In 2022, the company invested €503.7 million in R&D.
• Quality Manufacturing: Stevanato Group maintains high standards across its 7 manufacturing facilities in 4 countries to ensure product integrity.
• Global Market Presence: Serving 85 countries, the company ensures its solutions are accessible worldwide.

Stevanato Group aims to empower its partners by creating a reliable ecosystem that supports the production of safe, easy-to-use, and cost-effective treatments, ultimately improving patients' lives. This commitment is reflected in their operations, which span glass primary packaging, drug delivery systems, and inspection machines for the pharmaceutical industry.

For the fiscal year 2024, Stevanato Group reported a revenue increase of 2% to €1,104 million, with high-value solutions representing 38% of the total revenue. This financial performance underscores the company's dedication to delivering high-quality products and services.

Stevanato Group's vision is centered on driving technological innovations that integrate products and processes into cohesive systems. By achieving this, the company aims to ensure the integrity of parenteral drugs to a degree that surpasses previous achievements. Stevanato Group is committed to being the best, objective-focused partner in the research and delivery of innovative solutions that support the success of its customers.

The company's values and guiding principles further support its mission and vision:

• Trust and respect everyone.
• Be accountable.
• Be ethical, always.
• Listen and communicate with transparency and honesty.
• Deliver results.

These values, combined with guiding principles such as 'Will to win well, have a big goal,' 'Don't be standard,' and 'Competence, experience, and preparation,' drive the Group towards achieving its mission.

Stevanato Group operates through two primary divisions:

• Pharmaceutical Systems: Specializes in ready-to-use glass containers, bulk primary packaging (syringes, cartridges, vials, and ampoules), and high-precision plastic solutions for diagnostic, pharmaceutical, and medical device applications.
• Engineering Systems: Focuses on glass forming technology, inspection systems, assembly, packaging machines, and serialization solutions for the pharmaceutical industry.

This structure enables Stevanato Group to maintain complete control over the entire production process, ensuring exceptional customer service.

Stevanato Group's commitment to innovation and quality is evident in its financial results and strategic initiatives. In 2024, the company saw a 15% increase in revenue from high-value solutions, reaching €422.3 million, which accounted for 38% of the total company revenue, compared to 34% in the previous year. The company's focus on expanding capacity and improving manufacturing facilities in locations like Fishers, Indiana, and Latina, Italy, further demonstrates its dedication to meeting customer demand and enhancing its market position.

To gain more insights into the company's financial performance, consider reading Breaking Down Stevanato Group S.p.A. (STVN) Financial Health: Key Insights for Investors.

Stevanato Group S.p.A. (STVN) Vision Statement of

Stevanato Group's mission is to provide its shareholders with a high return on invested capital, and this goal is integrated into the company's overall strategy. The company aims to achieve this by:

• Focusing on innovation.
• Operating efficiently.
• Meeting customer expectations.

Stevanato Group strives to create value for its customers, employees, and shareholders by:

• Offering high-quality products and services.
• Being a reliable partner.
• Operating in a sustainable manner.

Here's an analysis of Stevanato Group's mission, vision, and core values:

Mission: To provide shareholders with a high return on invested capital.

Analysis: This mission statement is direct and focused on financial performance. It emphasizes the company's commitment to delivering value to its shareholders through efficient operations, innovation, and customer satisfaction.

Vision: Stevanato Group doesn't have a single, explicitly stated vision statement, but its vision can be inferred from its strategic goals and values. The vision is to be a global leader in providing innovative solutions for the pharmaceutical and healthcare industries, creating value for customers, employees, and shareholders while operating sustainably.

Analysis: The inferred vision highlights the company's ambition to lead in its industry by focusing on innovation and sustainability. This broader vision encompasses not only financial returns but also the company's impact on its stakeholders and the environment.

Core Values: Stevanato Group's core values are not explicitly listed, but they can be inferred from its actions and statements. These values include:

• Innovation: Developing new and improved solutions for the pharmaceutical and healthcare industries.
• Customer Focus: Meeting and exceeding customer expectations.
• Quality: Providing high-quality products and services.
• Reliability: Being a dependable partner.
• Sustainability: Operating in an environmentally and socially responsible manner.

Analysis: These inferred core values reflect Stevanato Group's commitment to excellence in all aspects of its business. By focusing on innovation, customer satisfaction, quality, reliability, and sustainability, the company aims to build long-term relationships with its stakeholders and create lasting value.

Here is more information regarding Stevanato Group S.p.A. (STVN) Financial Health: Breaking Down Stevanato Group S.p.A. (STVN) Financial Health: Key Insights for Investors

Stevanato Group S.p.A. (STVN) Core Values

Stevanato Group operates with a clearly defined set of core values. While specific, publicly available details on each core value with explicit examples are limited, we can infer their values from their actions, strategic priorities, and overall company statements. More background information can be found here: Stevanato Group S.p.A. (STVN): History, Ownership, Mission, How It Works & Makes Money

Customer Focus

A commitment to understanding and meeting customer needs is paramount. This involves not only providing high-quality products but also building strong, lasting relationships with clients. For example, Stevanato Group partners with pharmaceutical companies to provide drug containment, delivery and diagnostic solutions. In 2024, the company reported a revenue of €1.2 billion, reflecting strong customer demand and satisfaction.

Innovation

Stevanato Group emphasizes innovation as a driver of growth and a means to maintain a competitive edge. This includes investing in research and development to create new products and improve existing ones. In 2024, Stevanato Group allocated €68.2 million to R&D, demonstrating their commitment to innovation. This investment supports the development of advanced solutions for drug delivery and containment.

Quality

Maintaining high standards of quality in all aspects of the business is crucial. This includes ensuring that products meet or exceed regulatory requirements and that processes are continuously improved. Stevanato Group's dedication to quality is reflected in its compliance with stringent industry standards. The company's quality control processes ensure that its products meet the highest standards, reducing the risk of defects and ensuring customer satisfaction.

People Development

Investing in the growth and development of employees is a key value. This includes providing opportunities for training, advancement, and personal growth. Stevanato Group recognizes that its employees are its greatest asset and invests in their development through various programs. As of 2024, Stevanato Group employed over 9,400 people worldwide, offering comprehensive training and development programs to enhance their skills and career prospects.

Sustainability

Stevanato Group is committed to minimizing its environmental impact and operating in a sustainable manner. This includes reducing waste, conserving resources, and promoting responsible business practices. The company's sustainability initiatives include reducing greenhouse gas emissions, conserving water, and promoting recycling. In 2024, Stevanato Group reported a 15% reduction in carbon emissions compared to its 2020 baseline.

Integrity

Upholding the highest ethical standards in all business dealings is essential. This includes being honest, transparent, and fair in all interactions. Stevanato Group's commitment to integrity is reflected in its code of conduct and ethical business practices. The company ensures that all employees adhere to these standards, fostering a culture of trust and accountability.